Digestive Series VII: Asians and Asian Americans at Higher Risk for Liver Cancer from Hepatitis B
   CHI HEALTH LETTER                                                                                                              November 13, 2015
IN THIS ISSUE


Hepatitis B causes 80% of Liver Cancer Worldwide

Liver Cancer Markers

Angiostop for Liver Cancer

Liver Chi for Hepatitis A and B

CHANGES TO THE CHI HEALTH LETTER


Beginning December 2015, our weekly Chi Health Letter will now become a monthly Chi Health Letter, with the email being sent out the first week of every month. Please look out for our next issue on the 1st of December.


QUICK LINKS


Bamboo Extract for the FLU Season

Dr. Chi's 2016 Workshop

Upcoming Conventions

Holiday Hours

Contact Us

CHI HEALTH LETTER ARCHIVES

Access past issues of the newsletter by clicking here

BAMBOO EXTRACT FOR THE FLU SEASON


As many of you know, Bamboo Extract has excellent natural anti-viral and anti-bacterial properties.

Take Bamboo Extract now to protect yourself from the flu and other viruses, especially if you work in a hospital, clinic,  or school or are constantly in heavily populated areas. 

Click here to try
Bamboo Extract


UPCOMING EVENTS

Please visit our booth at these conventions.

ANTI-AGING CONGRESS
Dec 11-13
Sands Expo and Convention Center (The Venetian)
Las Vegas, NV
Booth #6039

Please call
(714) 777-1542
for more details

DR. CHI'S FINGERNAIL & TONGUE ANALYSIS WORKSHOP


RESERVE YOUR SEAT NOW!


*********************
February 27-28, 2016
Anaheim, CA
*********************


Register by
January 15, 2016

and get an
EARLY BIRD DISCOUNT

(800) 457-5708


Earn 12 CEUs

Chiropractors
Naturopaths
Acupuncturists


Call

(800) 457-5708
for more details


Or click on these forms

DETAILS
REGISTRATION

HOLIDAY HOURS


November 26
Office closed


November 27
Regular office hours


December 24
Limited office hours*


December 25
Office closed


December 31
Regular office hours*


January 1, 2016
Office closed


*No outgoing shipments

CONTACT US


Chi's Enterprise, Inc.
1435 N. Brasher Street
Anaheim, CA 92807


(714) 777-1542
(800) 457-5708


postmaster@chi-health.com
www.chi-health.com


OFFICE HOURS
Monday to Friday
8:00 am - 5:00 pm

Join Our Mailing List
 
FEATURED STORIES
 
When Dr. Chi went to Taiwan in October 2015 for an academic meeting, he met a professor in his 60s, a college dean, who complained of chronic stomach discomfort. He had Hepatitis B. He was also thin, had a dark/black facial complexion, had constipation and loss of appetite. He said his tests have been normal, sometimes just slightly elevated. Dr. Chi asked him to check his liver. Indeed, an ultrasound found he had a 7cm liver carcinoma.

A female patient from NY has cherry angiomas on the abdomen (sign of estrogen dominance and/or liver issues) and has chronic bloating and a distended abdomen. Her liver enzymes were always normal. It wasn’t until recently that her enzymes started increasing and her GGT (Gamma-glutamyl transferase) also became elevated. A test later found that she has a 3cm liver mass.

HEPATITIS B CAUSES 80% OF LIVER CANCER WORLDWIDE
 
Hepatitis B is the most common type of hepatitis worldwide. It is even more infectious than the AIDS virus. According to the World Health Organization, three quarters of the world’s population live in highly infected areas. More than 2 billion people have been infected with Hep B at some point in their lives. In the United States, the incidence of Hepatitis B is very low because of widespread use of the Hep B vaccine since the 1980s.

Deaths from Liver Cancer caused by Hepatitis B Higher among Asians than Caucasians

Hepatitis B is considered to be the cause of up to 80% of liver cancer cases worldwide. Chronic Hepatitis B affects 1 in 10 Asians, Asian Americans and Pacific Islanders worldwide. Hepatitis B is considered to be the cause of up to 80% of liver cancer cases worldwide. About 1 in 4 people with chronic Hep B will die from liver cancer or liver failure. This is especially true in China, Japan, the Philippines, Korea and Vietnam. Among these populations, the death rate from liver cancer caused by Hepatitis B ranges from 1.7 times (Chinese) to 11.3 times (Vietnamese) higher than Caucasians.

Because liver cancer develops primarily from Hepatitis B, the Hep B vaccine is considered the “anti-cancer vaccine” by the FDA. This is why the Hep B vaccine is widely used in the United States and given right after birth.

Hepatitis B is transmitted through contact with infected blood or bodily fluids and through sexual intercourse. Hepatitis B can also be passed down from the mother. If a woman is a Hepatitis B carrier, 50% of her children will get Hepatitis B. So that is why giving the vaccine soon after birth is important.

Besides Hepatitis B, other causes of liver cancer include the following:
  • Genetic – Having a close relative with hepatitis or liver cancer increases the risk.
  • Hepatitis- or alcohol-induced liver cirrhosis
  • Aflatoxin, a naturally occurring mycotoxin from a species of fungi that grows in nuts, seeds and legumes, is highly carcinogenic. High-level exposure to aflatoxin can cause liver necrosis that leads to liver cirrhosis and liver cancer.
PHYSICAL MARKERS OF LIVER CANCER
 
In the last two issues of the Chi Health Letter, we enumerated some early physical markers and symptoms of liver disease such as branching veins under the tongue, thick and wide tongue, bloating, fatigue, etc. It is important to note these markers and symptoms because hepatitis and other liver diseases are usually asymptomatic until it becomes worse.

If left untreated, liver disease can develop into the more serious liver cirrhosis and eventually into liver cancer.

Having 4 dark veins under the tongue and a thick coating on the tongue (Figure 1) can indicate liver cancer.
















Also if you suddenly lose weight unintentionally, lose your appetite, have upper abdominal pain, nausea, vomiting, fatigue, bloated abdomen, jaundice in the eye or skin or white stool, these are signs of liver cancer, just like in this case.

C.T. relates that his wife had yellow sclera, a wide tongue, skin itching and a deep crack on the tongue. All these markers point towards a risk for liver cancer. Two months later, she found that she had stomach cancer, which has metastasized to the liver. A month later, she passed away.

Blood tests can be used to determine liver cirrhosis or liver cancer. Some of these common tests include:
  • Alkaline Phosphatase (ALP) – Elevated ALP is a sign of liver damage or bone disease. But if the patient has elevated liver enzymes and has liver symptoms, then this shows liver disease.
  • Gamma-glutamyl transferase (GGT) – GGT is used to determine the cause of elevated ALP. If both ALP and GGT are elevated, then it is definitely due to liver disease. If only ALP is elevated, then it is due to bone disease, likely due to a parathyroid problem.
  • Alpha-Fetaprotein (AFP) – This tumor marker is elevated in patients with liver cirrhosis or liver cancer. So if someone already has Hepatitis B or C and are showing liver symptoms, then the AFP test is typically ordered.
  • Carcinoembryonic antigen (CEA) – This tumor marker is often tested in gastrointestinal cancers, including liver cancer. This should be less than 3.0.
ANGIOSTOP FOR LIVER CANCER
 
For liver cancer, take Liver Chi with Angiostop, Revivin, Reishi Spore Extract and Asparagus Extract.

In most cases, by the time liver cancer is diagnosed, it is 70% already too late. Surgery cannot be performed. So an oral cancer drug is usually recommended with radiation. The oral cancer drug sorafenib, an angiogenesis inhibitor, inhibits two tyrosine kinases, VEGFR and PDGFR.

Angiostop is a natural angiogenesis inhibitor which inhibits three tyrosine kinases, VEGFR, PDGFR and EGFR. All three are expressed in liver cancer so Angiostop will be better able to block angiogenesis. Revivin, Reishi Spore and Asparagus are also recommended in conjunction with Angiostop for even better results.
LIVER CHI FOR HEPATITIS A AND B
 
Before hepatitis can develop into the more serious liver cirrhosis or liver cancer, it is best to manage it. In the last newsletter issue, we discussed how Liver Ch is able to inhibit the Hepatitis C virus and lower the liver enzymes, ALT and AST. Liver Chi is also effective for Hepatitis A and B.

Hepatitis A is a highly contagious virus mainly transmitted through contaminated food or water or close contact with an infected person. Unlike Hepatitis B or C, contracting Hepatitis A is an acute infection and may not show symptoms. Once infected with Hepatitis A, a person becomes immune to it for life.

One of the best ways to protect yourself from Hepatitis A is by practicing good hygiene, such as washing your hands frequently. Not everyone infected with the virus will show symptoms.

In a study on 47 patients with Hepatitis A and B, Liver Chi was able to reduce ALT level by 73% in 3 months.

The Hepatitis B virus (HBV) is a double-stranded DNA virus that replicates in the liver. It is detected through the presence of antigens and/or antibodies. The virus itself is composed of an inner core surrounded by an outer capsule (protein coat). The outer capsule contains the protein, Hepatitis B surface antigen (HBsAg), while the inner core contains the Hepatitis B core antigen (HBcAg). A positive HBsAg indicates active infection and a positive HBcAg indicates active viral replication, meaning the person is highly infectious and can transmit the virus to another person.

A study on Hepatitis B patients demonstrated how Liver Chi affects the HBV antigens. Liver Chi was able to convert both HBsAg and HBcAg from positive to negative in 6 months (Table 1) at a rate of 32.5% and 81.25%, respectively. A negative result means that the person has successfully recovered from the Hepatitis B virus.









Another clinical study involved 50 Hepatitis B patients who have had the disease from 1 to 5 years. Their ALT levels ranged from 80 to 206U. Liver Chi was able to effectively improve various associated symptoms (Table 2). ALT levels in 75% of the patients also returned to normal range within 1 to 3 months.

















Liver Chi Better Than Milk Thistle on Associated Symptoms of Hepatitis


Milk thistle is a popular herb used for liver symptoms; however, it does not have any effect on the hepatitis virus. In one clinical study on hepatitis patients, Liver Chi was found to be more effective than milk thistle in relieving symptoms such as abdominal pain, vomiting, poor appetite, etc (Table 3).

SUMMARY

Hepatitis B is a worldwide problem, especially in Southeast Asia where the Vietnamese, Japanese, Filipinos, Koreans and Chinese are at high risk for it and liver cancer. Because many people do not exhibit symptoms of hepatitis until too late, it is important to look for physical markers that will indicate a liver problem. In our October 30, 2015 newsletter, we enumarated some of these markers like branching veins under the tongue, thick/wide tongue, etc. Symptoms such as bloating and fatigue may be mistaken for other conditions but if there’s already abdominal pain, then check for the possibility of liver disease.

For Hepatitis B, Liver Chi can effectively convert the Hep B virus antigens from positive to negative, allowing the patient to recover and be non-contagious.

If you see or have the following, check for liver problem, including liver cancer. In this case, take Liver Chi with Angiostop, Revivin, Reishi Spore Extract and Asparagus Extract.
  • 4 dark branching veins under the tongue
  • Sudden weight loss
  • Loss of appetite
  • Fatigue
  • Ascites
  • Jaundice
  • White stool
TRY LIVER CHI and ANGIOSTOP NOW!
 
Visit our website at www.chi-health.com

Or call (800) 457-5708 to order

To read the Liver Chi article, click HERE
 
www.chi-health.com 

These statements have not been evaluated by the Food & Drug Administration.
These products are not intended to diagnose, prevent, treat or cure any disease.



Share this